Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles

Fertility and Sterility

Volumn 104, Issue 3, 2015, Pages 637-642

  Meyer, Laura ^a   Murphy, Lauren A ^a   Gumer, Arielle ^b   Reichman, David E ^a   Rosenwaks, Zev ^a   Cholst, Ina N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Complications; donor egg; empty follicle syndrome; fertility preservation; GnRH agonist; OHSS; ovulation trigger; prevention of OHSS; suboptimal response

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; BIOLOGICAL MARKER; FERTILITY PROMOTING AGENT; GONADORELIN;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG RESPONSE; FEMALE; FERTILIZATION IN VITRO; HORMONAL CONTRACEPTION; HORMONE RESPONSE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; OVULATION INDUCTION; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; AGONISTS; BLOOD; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; FERTILITY; INFERTILITY; MENSTRUATION DISORDER; PATHOPHYSIOLOGY; PREGNANCY; TREATMENT FAILURE;

ADULT; BIOMARKERS; CHORIONIC GONADOTROPIN; CONTRACEPTIVES, ORAL, HORMONAL; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; LEUPROLIDE; LUTEINIZING HORMONE; MENSTRUATION DISTURBANCES; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 84940721751     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.06.011     Document Type: Article

References (16)

1. D. Bodri, J.J. Guillen, A. Galindo, D. Mataro, A. Pujol, and O. Coll Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil Steril 91 2009 365 371
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
3. L. Engmann, and C. Benadiva Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support Fertil Steril 97 2012 531 533
4. L. Engmann, L. Siano, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod Biomed Online 13 2006 639 644
5. N.E. Kummer, R.S. Feinn, D.W. Griffin, J.C. Nulsen, C.A. Benadiva, and L.L. Engmann Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger Hum Reprod 28 2013 152 159
6. S.L. Chen, D.S. Ye, X. Chen, X.H. Yang, H.Y. Zheng, Y. Tang, and et al. Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol Hum Reprod 27 2012 1351 1356
7. B.S. Shapiro, S.T. Daneshmand, H. Restrepo, F.C. Garner, M. Aguirre, and C. Hudson Efficacy of induced luteinizing hormone surge after "trigger" with gonadotropin-releasing hormone agonist Fertil Steril 95 2011 826 828
8. K.N. Maxwell, I.N. Cholst, and Z. Rosenwaks The incidence of both serious and minor complications in young women undergoing oocyte donation Fertil Steril 90 2008 2165 2171
9. D.E. Reichman, E. Greenwood, L. Meyer, I. Kligman, and Z. Rosenwaks Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection? Fertil Steril 98 2012 671 674
10. D.E. Reichman, V. Gunnala, L. Meyer, S. Spandorfer, G. Schattman, O.K. Davis, and et al. In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation? Fertil Steril 100 2013 94 99
11. A.M. Haavisto, K. Pettersson, M. Bergendahl, A. Virkamaki, and I. Huhtaniemi Occurrence and biological properties of a common genetic variant of luteinizing hormone J Clin Endocrinol Metab 80 1995 1257 1263
12. S. Altmae, O. Hovatta, A. Stavreus-Evers, and A. Salumets Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 17 2011 813 828
13. L. Chevrier, F. Guimiot, and N. de Roux GnRH receptor mutations in isolated gonadotropic deficiency Mol Cell Endocrinol 346 2011 21 28
14. K. Furui, N. Suganuma, S. Tsukahara, Y. Asada, F. Kikkawa, M. Tanaka, and et al. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants J Clin Endocrinol Metab 78 1994 107 113
15. H. Pinkas, O. Sapir, O.M. Avrech, A. Ben-Haroush, J. Ashkenzi, B. Fisch, and et al. The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome J Assist Reprod Genet 25 2008 29 33
16. G. Griesinger, C.A. Venetis, T. Marx, K. Diedrich, B.C. Tarlatzis, and E.M. Kolibianakis Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis Fertil Steril 90 2008 1055 1063